Vaccine Resources

Park County COVID19 Vaccine Resources

Upcoming Clinics: 

The following clinics offer Moderna, Pfizer and Johnson & Johnson vaccines available for first, second, third and booster doses for eligible populations. Appointments and walk-ins accepted! 

Please bring your vaccine card(s) if this is not your first dose.

  • Oct. 28 - Bailey Community Center, 83 Main St. Bailey CO 80421 Noon – 6 PM. Register here. 
  • Oct. 30 - Fairplay Community Center, 880 Bogue Street, Fairplay, CO 10 AM - 2 PM Register here.
  • Nov. 4 - Bailey Community Center, 83 Main St. Bailey CO 80421, 12 - 6 PM Register here.
  • Nov. 6 - Lake George, location TBD, 9 - 11 AM Register here.
  • Nov. 6 - Guffey, location TBD, 3 - 5 PM Register here.
  • Nov. 11 - Bailey Community Center, 83 Main St. Bailey CO 80421, 12 - 6 PM  Register here.
  • Nov. 13 - Fairplay Community Center, 880 Bogue Street, Fairplay, CO 10 AM - 2 PM  Register here.
  • Nov. 18 - Bailey Community Center, 83 Main St. Bailey CO 80421, 12 - 6 PM  Register here.
  • Nov. 20 - Lake George, location TBD, 9 - 11 AM Register here.
  • Nov. 20 - Guffey, location TBD, 3 - 5 PM Register here.

Other Vaccine Clinic Resources and Options

The following information has been provided by each hospital system, facility, or provider regarding vaccine distribution plans and options for patients. Please visit their websites to learn more:

Booster Shots and Third Doses 

New! On Oct. 21, the Centers for Disease Control and Prevention (CDC) recommended Moderna and Janssen (Johnson & Johnson) COVID-19 vaccine booster doses for people at higher risk for COVID-19. Please see details below for recommendations on all three vaccine types. Please bring your vaccine card(s) when you receive your booster shot! 

MODERNA: the updated CDC guidance recommends Moderna booster doses for people:

  • 65 years and older, 
  • residents in long-term care settings, 
  • people aged 18–64 years with underlying medical conditions, and 
  • people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of where they work or live. 

People who originally received the Moderna vaccine may get a booster dose approximately six months or more after they received their second dose of vaccine. 

JOHNSON & JOHNSON: Booster doses are also recommended for:

  • anyone age 18 and older who received the Johnson & Johnson vaccine. 

People who originally received the Johnson & Johnson vaccine may get a booster dose approximately two months or more after their single dose.

CDC also authorized a “mix and match” approach to booster doses. People may get a different type of vaccine for their booster than their original series. For example, if you received a Johnson & Johnson vaccine for your first dose, you may choose to get a booster dose of Pfizer, Moderna, or Johnson & Johnson.  

PFIZER: On September 24, CDC recommended that the following groups should receive a booster shot of Pfizer-BioNTech’s COVID-19 Vaccine at least 6 months after completing their Pfizer-BioNTech primary series (i.e., the first 2 doses of a COVID-19 vaccine):

  • people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
  • people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series,
  • people aged 18–49 years with underlying medical conditions may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks, and
  • people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech’s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risks.

Third COVID19 Vaccine Dose Approved for Limited Immunocompromised Populations: On August 12, the the Food and Drug Administration (FDA) amended Emergency Use Authorizations for both the Pfizer and Moderna COVID-19 vaccines to allow for the use of an additional dose after the first two doses in certain immunocompromised people. If you have questions, please contact your primary care physician.

People who are recommended to receive an additional dose include people who have:

  • Been receiving active cancer treatment for tumors or cancers of the blood.
  • Received an organ transplant and are taking medicine to suppress the immune system.
  • Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system.
  • Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome).
  • Advanced or untreated HIV infection.
  • Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response. 

Additional details regarding this latest announcement include: 

  • The additional dose should be the same vaccine product as the first two doses. However, an alternate mRNA dose can be used if that vaccine is not available. 
  • People should not receive more than three mRNA COVID-19 vaccine doses.
  • Authorizing an additional dose of the vaccine for immunocompromised Coloradans will help increase their protection and prevent more severe illness, hospitalization, and death.
  • Additional doses are free. No ID, insurance, or proof of medical history is required to receive an additional dose. Coloradans may self-report their immunocompromising conditions to vaccine providers. 
  • Patients can find vaccine providers at: www.covid19.colorado.gov/vaccinefinder 

Electronic Proof of COVID19 Vaccine

Do you need proof of your COVID-19 vaccine? You can visit the the state's website and save an electronic version of the same format as the paper CDC card the user received when they were vaccinated. myColorado app users can download a copy to their device, refresh or delete the record.

Vaccine Types

Safety and Monitoring:

  • On July 13, the FDA published a press release and sent a fact sheet and another fact sheet to healthcare providers (i.e.doctors, nurses, hospitals, etc.) about a recent safety signal they detected: Guillain-Barre Syndrome (GBS). Based on an analysis of Vaccine Adverse Event Reporting (VAERS) data, the FDA found 100 reports of GBS following 12.5 million vaccines. Out of the 100 cases, 95% were serious and required hospitalization. One person died.
  • On June 23, CDC issued a safety concern associated with Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination
  • On April 23, the press release from the FDA and CDC, who determined the use of the Janssen COVID-19 Vaccine should be resumed in the United States and that the FDA and CDC have confidence that this vaccine is safe and effective in preventing COVID-19. CDPHE has decided to proceed by including FDA’s updated warning to patients about the increased risk of very rare but potentially severe TTS, particularly among women under the age of 50.
  • On August 23, the  FDA granted full approval to the Pfizer COVID19 vaccine for ages 16 and older, marking an important milestone in the ongoing pandemic.
  • On August 11, the CDC released additional safety data related to pregnant people receiving the COVID19 vaccine, more details can be found here: https://www.cdc.gov/media/releases/2021/s0811-vaccine-safe-pregnant.html
  • The Johnson & Johnson and Moderna vaccines are authorized for ages 18 and older and the Pfizer vaccine is approved for 12 and older. Please check the clinic you are registering for carefully to ensure it is offering your preferred choice.
  • On May 10, the U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer COVID-19 Vaccine for the prevention of COVID-19 to include adolescents 12 through 15 years of age. The FDA previously amended the EUA for administration in individuals 16 years of age and older. All ages are subject to change.
  • Vaccine Finder: allows you to search by vaccine type and location in Colorado.
  • Overview of approved vaccines

Who Shouldn't Get a Vaccine?

The vaccines have received Emergency Use Authorization (EUA) by the FDA and are considered highly safe and effective at preventing COVID-19 infections. Most people 12 years and older (for Pfizer) and 18 and older (for Moderna and Johnson and Johnson vaccines) are able to safely receive the vaccine, but please contact your doctor if you:

  • Are currently in isolation or have a fever 24 hours after the end of isolation with no improvement in symptoms
  • Have been treated for COVID-19 within the last 90 days with monoclonal antibodies or convalescent plasma
  • Had a severe allergic reaction after a previous dose of this vaccine
  • Have had a severe allergic reaction to any ingredient of this vaccine.

A Compilation of Vaccine Resources and Information

The development and distribution a COVID-19 vaccine will require a large scale effort by state, local, and private sector partners. The first phase will focus on frontline health care workers, first responders, and our most vulnerable populations living in long-term care facilities. Until the vaccine is widely available to the general public, we all need to continue to follow critical public health protocols. Please wear a mask in public, maintain at least 6 feet of distance from others, avoid gatherings, wash your hands often, and stay home when you are sick.

Background:

Scientists have developed several possible vaccines to provide immunity to COVID-19.  Once a company develops a vaccine, it must go through a rigorous scientific testing process before it can be submitted to the Food and Drug Administration (FDA). The FDA independently reviews the information from these tests to make sure the vaccine is safe and works well, and then decides whether the vaccine can be licensed and made available to the public. The pharmaceutical companies Pfizer and Moderna have applied for an Emergency Use Authorization with the Food and Drug Administration (FDA). The FDA authorized the Pfizer vaccine for emergency use on December 11, and Colorado received the vaccine beginning December 14. Moderna vaccine is expected to arrive in Colorado the week of December 22.
Safety and Effectiveness:
The companies report that both vaccines are around 95% effective. While the development process was efficient, the world's leading vaccine companies, in conjunction with the FDA and independent scientists, have used the same rigorous structure to develop these vaccines as has been used for all other drug and vaccine development. These involve multiple studies or “phased trials” across many months with larger and larger groups of people to ensure that the vaccine is both safe and effective for the general public. Tens of thousands of individuals across the US and the world have volunteered and helped provide this important information.

About mRNA-1273, Moderna’s Vaccine Against COVID-19:

The Moderna vaccine, or mRNA-1273 works by helping the immune system produce effective antibodies against the SARS-CoV-2 virus so that, in case of infection, the virus does not cause illness. The vaccine cannot cause infection or make someone sick with COVID-19. Learn more about the Moderna vaccine safety and effectiveness by the FDA here.

Two-Dose Vaccines:

Both mRNA vaccines require two injections, given either 21 or 28 days apart. The first dose primes the immune system and the second dose helps boost the immune system even further to help provide better protection against the coronavirus. Two shots spaced apart are necessary as the Pfizer vaccine has been shown to be 95% effective after an individual receives 2 doses, however, only 52% effective if an individual receives just a single dose.


Other Trusted Resources

CDC Resources

Advisory Committee on Immunization Practices (ACIP) Guidelines

Colorado Resources

Other Vaccine Information